SynopsisHeart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swe.....
SynopsisThe global Homocysteine Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Homocysteine Testing is estimated to increase.....
SynopsisThe global ePTFE Vascular Graft market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026. This report focuses on ePTFE Vascular Graft volume and value at the global .....
SynopsisThe aorta is the major arterial conduit conveying blood from the heart to the systemic circulation. It originates immediately beyond the aortic valve ascending initially. Then it curves, forming the aortic arch, and descends caudally adjacent to the spine. The.....
Synopsis Due to the COVID-19 pandemic, the global Endomucin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the .....
SynopsisThe global Veterinary Thermography market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Thermography in various end use industries. The expandi.....
SynopsisUveitis is the third leading cause of blindness worldwide. The most common type of uveitis is an inflammation of the iris called iritis (anterior uveitis). Uveitis can damage vital eye tissue, leading to permanent vision loss. The global Non-infectious A.....
SynopsisNorth America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%. Donepezil's major manufacturers include Eisai, Pfizer, Teva, Novartis, etc. The top three companies account for about 60% of .....
SynopsisThe global Ubiquitin Proteasome market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ubiquitin Proteasome in various end use industries. The expanding dem.....
SynopsisThe global Frontotemporal Disorders Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Frontotemporal Disorders Treatment in various end use i.....
